<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2009-12-04 19:10:48Phosphodiesterase inhibitor Amrinone CGMP-specific phosphodiesterase type 5 Phosphodiesterase Phospholamban Rolipram Heart failure Myocyte CAMP-dependent pathway Biology Phosphodiesterase-4 inhibitor Pyridines |
Add to Reading List |
Phosphodiesterase 4D is required for 2 adrenoceptor subtype-specific signaling in cardiac myocytes Yang Xiang*†, Fabio Naro†‡§, Maria Zoudilova‡, S.-L. Catherine Jin‡, Marco Conti‡¶, and Brian Kobilka*¶
![The Journal of Neuroscience, December 6, 2006 • 26(49):12807–12815 • [removed]Development/Plasticity/Repair Imaging of cAMP Levels and Protein Kinase A Activity Reveals That Retinal Waves Drive Oscillations in](https://www.pdfsearch.io/img/6b10be0c5cad0907866e844bf8c89098.jpg "The Journal of Neuroscience, December 6, 2006 • 26(49):12807–12815 • [removed]Development/Plasticity/Repair Imaging of cAMP Levels and Protein Kinase A Activity Reveals That Retinal Waves Drive Oscillations in")
![0026-895X[removed]–583$3.00 MOLECULAR PHARMACOLOGY Copyright © 2001 The American Society for Pharmacology and Experimental Therapeutics Mol Pharmacol 60:577–583, 2001 Vol. 60, No. 3](https://www.pdfsearch.io/img/2903414e9f4a9519cd4457c97ddce9cc.jpg "0026-895X[removed]–583$3.00 MOLECULAR PHARMACOLOGY Copyright © 2001 The American Society for Pharmacology and Experimental Therapeutics Mol Pharmacol 60:577–583, 2001 Vol. 60, No. 3")